Contents

Current Vascular Pharmacology, Volume 9 - Number 5

“European Panel On Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses: Executive Summary

, 9(5): 531 - 532

Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin and Evangelos Liberopoulos


DOI: 10.2174/157016111796642698


“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses

, 9(5): 533 - 571

Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin and Evangelos Liberopoulos


DOI: 10.2174/157016111796642661


Medical Therapy of Aortic Aneurysms: A Pathophysiology-Based Approach

, 9(5): 572 - 584

Giovanna Muscogiuri, Gian Pio Sorice, Devjit Tripathy, Alberto O. Chavez, Alberto Davalli, Richard A. Lange and Franco Folli


DOI: 10.2174/157016111796642724



Aldosterone, From (Patho)Physiology to Treatment in Cardiovascular and Renal Damage

, 9(5): 594 - 605

Femke Waanders, Laura V. de Vries, Harry van Goor, Jan-Luuk Hillebrands, Gozewijn D. Laverman, Stephan J. L. Bakker and Gerjan Navis


DOI: 10.2174/157016111796642689






Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science